Safeguard Scientifics, Inc. · OTC:SFES
Safeguard Scientifics — Q1 2004 Earnings Presentation
19 slides from Safeguard Scientifics's earnings presentation, May 5, 2004
Slide 1: First Quarter 2004 Conference Call
Safeguard Scientifics, Inc. First Quarter 2004 Conference Call April 29, 2004
Slide 2: Forward Looking Statements
The statements contained in this presentation that are not historical facts are forward looking statements which involve certain risks and uncertainties including, but not limited to, risks associated with the uncertainty of managing rapidly changing technologies, limited access to capital, competit
Slide 3: Agenda
Agenda First Quarter Accomplishments Core Company Update Overview of Q1 2004 Financial Review 3
Slide 4: First Quarter Accomplishments
First Quarter Accomplishments • Placed $150M of 2.625% Convertible Senior Debentures; • Repurchased $86.5M of our 5% Convertible Notes due June 2006 with a portion of the proceeds from the new debt offering thru 3/31; $17.6M thru 4/27; • Received the proceeds from the sale of our interest in Tangram
Slide 5: ChromaVision Medical Systems
ChromaVision Medical Systems (NASDAQ:CVSN) • Raised $26M through private placement and PIPE • Named Michael Cola interim CEO • Patent granted which extends claims of ACIS(r) - total issued patents = 14 • Announced entry into Lab Service Market related to ACIS (r) Alliance Consulting • Made strong in
Slide 6: Mantas
Mantas • Executed new sales contracts of $9M in Q1 • Infosys Technologies Ltd joins Mantas Global Alliance Program • Cavalier Telephone selects Mantas' revenue assurance solutions • Sunrise Telecom announced partnership with Mantas to integrate its network monitoring analyzers with Mantas' revenue a
Slide 7: Current Strategic Focus
Current Strategic Focus Building pipeline with focus on opportunities in: • Business Decision Solutions - which includes companies focused on developing and delivering complex IT, software and service solutions that enable better and faster decision-making for targeted business users. These companie
Slide 8: Financial Review
Financial Review First Quarter 2004 Consolidated Results Update on Debt Offering and Dispositions Non-strategic Company Update Overview of Parent Company Cash & Marketable Securities 8
Slide 9: Q1 2004 vs. 2003 Financial Results
Q1 2004 vs. 2003 Financial Results ($ in millions) 9
Slide 10: Segment Results of Operations
Segment Results of Operations ($ in millions) 10
Slide 11: Strategic Company Financial Highlights
Strategic Company Financial Highlights (in millions) 11
Slide 12: Carrying Values
Carrying Values ($ in millions) 12
Slide 13: Debt Offering, Repurchase & Non-strategic Sales
Debt Offering, Repurchase & Non-strategic Sales $150M 2.625% Convertible Senior Debentures due 2024 7 year put by holders; 5 year no call; 2 year provisional call @ 140%. Convertible into SFE common stock at $7.22 - 38% premium over closing price prior to offering Proceeds from 2.625% Debentures to
Slide 14: Private Company Ownership Interests
Private Company Ownership Interests Current Voting % Owned Strategic Alliance Consulting 100% Mantas 84% Non-strategic Mobility Technologies 3% Neuronyx 7% NexTone Communications 27% Pacific Title & Art Studio 84% ProModel Solutions 33% REALTIME MEDIA 9% Ventaira Pharmaceuticals 11% 14
Slide 15: Public Company Ownership Interests - Market Value
Public Company Ownership Interests - Market Value ($ in millions) 15
Slide 16: Market Value of Public Company Interests and Parent Company Cash
Market Value of Public Company Interests Parent Company Cash Parent Company Cash and Market Value of Public Company Interests ($ in millions) 16
Slide 17: Parent Company Cash Outlook
Parent Company Cash Outlook Parent company cash balances from period to period are significantly impacted by: the pace of monetization activities the pace and size of acquisitions follow-on fundings to our companies and private equity funds 17
Slide 18: Safeguard Transformation
Safeguard Transformation 18 We believe Safeguard provides its shareholders with an efficient and liquid vehicle to participate in certain stages of our companies' growth that are not generally available to investors in the public market. Safeguard is: operationally focused, financially strong, with
Slide 19: Safeguard Scientifics, Inc. First Quarter 2004 Conference Call
Safeguard Scientifics, Inc. First Quarter 2004 Conference Call April 29, 2004
Safeguard Scientifics — Q1 2004 Earnings Presentation on 6ix